These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 36104962)

  • 1. [Diagnostic value of ct in examination of patients with adrenal cancer].
    Rusakov VF; Shcherbakov IE; Chinchuk IK; Savelyeva TV; Rebrova DV; Loginova OI; Pridvizhkina TS; Chernikov RA; Krasnov LM; Fedotov JN; Fedorov EA; Sablin IV; Sleptsov IV; Shihmagomedov SS; Zgoda EA
    Probl Endokrinol (Mosk); 2022 Apr; 68(4):13-29. PubMed ID: 36104962
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adrenocortical carcinomas and adrenal pheochromocytomas: mass and enhancement loss evaluation at delayed contrast-enhanced CT.
    Szolar DH; Korobkin M; Reittner P; Berghold A; Bauernhofer T; Trummer H; Schoellnast H; Preidler KW; Samonigg H
    Radiology; 2005 Feb; 234(2):479-85. PubMed ID: 15671003
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CT imaging characteristics of oncocytic adrenal neoplasms (OANs): comparison with adrenocortical carcinomas.
    Khan M; Caoili EM; Davenport MS; Poznanski A; Francis IR; Giordano T; Dunnick NR
    Abdom Imaging; 2014 Feb; 39(1):86-91. PubMed ID: 24271078
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Small adrenal incidentaloma becoming an aggressive adrenocortical carcinoma in a patient carrying a germline APC variant.
    Gagnon N; Boily P; Alguire C; Corbeil G; Bancos I; Latour M; Beauregard C; Caceres K; El Haffaf Z; Saad F; Olney HJ; Bourdeau I
    Endocrine; 2020 Apr; 68(1):203-209. PubMed ID: 32088909
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An Interesting Case of Hepatic Adrenocortical Carcinoma.
    Permana H; Darmawan G; Ritonga E; Kusumawati M; Miftahurachman M; Soetedjo NN
    Acta Med Indones; 2018 Jul; 50(3):257-259. PubMed ID: 30333277
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Critical Analysis of Computed Tomography Washout in Lipid-Poor Adrenal Incidentalomas.
    Akbulut S; Erten O; Kahramangil B; Gokceimam M; Kim YS; Li P; Remer EM; Berber E
    Ann Surg Oncol; 2021 May; 28(5):2756-2762. PubMed ID: 33210268
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CT features and quantification of the characteristics of adrenocortical carcinomas on unenhanced and contrast-enhanced studies.
    Zhang HM; Perrier ND; Grubbs EG; Sircar K; Ye ZX; Lee JE; Ng CS
    Clin Radiol; 2012 Jan; 67(1):38-46. PubMed ID: 21783181
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A case of adrenocortical carcinoma diagnosed 9 years after the discovery of adrenal incidentaloma.
    Aono D; Kometani M; Asano T; Konishi S; Karashima S; Ikeda H; Nohara T; Yoneda T
    Endocr J; 2022 Dec; 69(12):1415-1421. PubMed ID: 35934796
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The computed tomography adrenal wash-out analysis properly classifies cortisol secreting adrenocortical adenomas.
    Humbert AL; Lecoanet G; Moog S; Bouderraoui F; Bresler L; Vignaud JM; Chevalier E; Brunaud L; Klein M; Cuny T
    Endocrine; 2018 Mar; 59(3):529-537. PubMed ID: 29332161
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Computed tomography criteria for discrimination of adrenal adenomas and adrenocortical carcinomas: analysis of the German ACC registry.
    Petersenn S; Richter PA; Broemel T; Ritter CO; Deutschbein T; Beil FU; Allolio B; Fassnacht M;
    Eur J Endocrinol; 2015 Apr; 172(4):415-22. PubMed ID: 25599706
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interobserver agreement in distinguishing large adrenal adenomas and adrenocortical carcinomas on computed tomography.
    Thomas AJ; Habra MA; Bhosale PR; Qayyum AA; Ahmed K; Vicens R; Elsayes KM
    Abdom Radiol (NY); 2018 Nov; 43(11):3101-3108. PubMed ID: 29671009
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [CCAFU's contribution to the French National Cancer Institute's reference frame: Adrenal malignant tumors].
    Sèbe P; Rigaud J; Avancès C; Brunaud L; Caillard C; Camparo P; Carnaille B; Durand X; Fléchon A; Murez T; Mathonnet M; Triponez F; Mirallié E; Coloby P; Soulié M; ;
    Prog Urol; 2013 Nov; 23 Suppl 2():S167-74. PubMed ID: 24485291
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adrenal wash-out CT: moderate diagnostic value in distinguishing benign from malignant adrenal masses.
    Schloetelburg W; Ebert I; Petritsch B; Weng AM; Dischinger U; Kircher S; Buck AK; Bley TA; Deutschbein T; Fassnacht M
    Eur J Endocrinol; 2021 Dec; 186(2):183-193. PubMed ID: 34813495
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumour size in adrenal tumours: its importance in the indication of adrenalectomy and in surgical outcomes-a single-centre experience.
    Mínguez Ojeda C; Gómez Dos Santos V; Álvaro Lorca J; Ruz-Caracuel I; Pian H; Sanjuanbenito Dehesa A; Burgos Revilla FJ; Araujo-Castro M
    J Endocrinol Invest; 2022 Oct; 45(10):1999-2006. PubMed ID: 35748977
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Urine steroid metabolomics for the differential diagnosis of adrenal incidentalomas in the EURINE-ACT study: a prospective test validation study.
    Bancos I; Taylor AE; Chortis V; Sitch AJ; Jenkinson C; Davidge-Pitts CJ; Lang K; Tsagarakis S; Macech M; Riester A; Deutschbein T; Pupovac ID; Kienitz T; Prete A; Papathomas TG; Gilligan LC; Bancos C; Reimondo G; Haissaguerre M; Marina L; Grytaas MA; Sajwani A; Langton K; Ivison HE; Shackleton CHL; Erickson D; Asia M; Palimeri S; Kondracka A; Spyroglou A; Ronchi CL; Simunov B; Delivanis DA; Sutcliffe RP; Tsirou I; Bednarczuk T; Reincke M; Burger-Stritt S; Feelders RA; Canu L; Haak HR; Eisenhofer G; Dennedy MC; Ueland GA; Ivovic M; Tabarin A; Terzolo M; Quinkler M; Kastelan D; Fassnacht M; Beuschlein F; Ambroziak U; Vassiliadi DA; O'Reilly MW; Young WF; Biehl M; Deeks JJ; Arlt W;
    Lancet Diabetes Endocrinol; 2020 Sep; 8(9):773-781. PubMed ID: 32711725
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adrenal Neoplasms: Lessons from Adrenal Multidisciplinary Tumor Boards.
    Chung R; Garratt J; Remer EM; Navin P; Blake MA; Taffel MT; Hackett CE; Sharbidre KG; Tu W; Low G; Bara M; Carney BW; Corwin MT; Campbell MJ; Lee JT; Lee CY; Dueber JC; Shehata MA; Caoili EM; Schieda N; Elsayes KM
    Radiographics; 2023 Jul; 43(7):e220191. PubMed ID: 37347698
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular Imaging in the Management of Adrenocortical Cancer: A Systematic Review.
    Wong KK; Miller BS; Viglianti BL; Dwamena BA; Gauger PG; Cook GJ; Colletti PM; Rubello D; Gross MD
    Clin Nucl Med; 2016 Aug; 41(8):e368-82. PubMed ID: 26825212
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CT features of adrenal pheochromocytomas: attenuation value and loss of contrast enhancement.
    Kalra MK; Blake MA; Boland GW; Hahn PF
    Radiology; 2005 Sep; 236(3):1112-3. PubMed ID: 16118181
    [No Abstract]   [Full Text] [Related]  

  • 19. 18F-FDG PET for the identification of adrenocortical carcinomas among indeterminate adrenal tumors at computed tomography scanning.
    Nunes ML; Rault A; Teynie J; Valli N; Guyot M; Gaye D; Belleannee G; Tabarin A
    World J Surg; 2010 Jul; 34(7):1506-10. PubMed ID: 20396886
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Deep learning approach for differentiating indeterminate adrenal masses using CT imaging.
    Singh Y; Kelm ZS; Faghani S; Erickson D; Yalon T; Bancos I; Erickson BJ
    Abdom Radiol (NY); 2023 Oct; 48(10):3189-3194. PubMed ID: 37369921
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.